Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancerNicole Williams, Robert Wesolowski, Adam Brufsky et al.|Therapeutic Advances in Medical Oncology|2023Cited by 14
Randomized placebo-controlled, double-blind clinical trial of nanoemulsion curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP pilot trialMaryam B. Lustberg, Patty Fan‐Havard, F. Lennie Wong et al.|Breast Cancer Research and Treatment|2024Cited by 12